Managing Hyperlipidemia in Adults with Chronic Kidney Disease

Document Type


Publication Date



Patients with hyperlipidemia and chronic kidney disease (CKD) are at high risk for cardiovascular complications, including myocardial infarction, stroke, and arrhythmias. Patients with renal dysfunction should be closely monitored and treated with lipid-lowering therapy to reduce morbidity and mortality. While statins are the primary lipid-lowering therapy recommended in patients with CKD, other antihyperlipidemia medication classes include fibrates, bile acid sequestrants, niacin, ezetimibe, and omega-3 fatty acids. Pharmacists can play a key role in providing recommendations for therapy initiation, medication adjustments in renal dysfunction, and education about medications and adherence.


This article was originally published in US Pharmacist in 2015.


Jobson Medical Information LLC